• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • Clinical Biostatistics

  • clinical-trials-header
  • Quintiles Clinical Trial

    Biostatistics in clinical trials isn’t just a necessity. With the right approach, it can be a competitive advantage.

    Founded by biostatisticians, Quintiles harnesses the power of clinical data analysis to fuel clinical trial success. Leveraging biostatistics in the planning stages of your drug development program, we can help you:

    • Reduce risks
    • Decrease costs
    • Accelerate timelines and speed results
    • Improve the quality of submissions.Learn more 

    Clinical biostatistics strategies that optimize your study design

    Our seasoned biostatisticians apply their deep regulatory knowledge to help you navigate the complexities of study design, sample size, number of studies, analysis methods, data displays and interpretations. You’ll also have access to our global pool of experts and resources, providing speed and flexibility with study reporting.

  • Expertise in biostatistics, clinical trials and how they intersect

  • Quintiles Clinical Trails

    Effective Analysis and Reporting is crucial to accurately packaging the evidence from your trial in your regulatory dossier. View presentation

  • Quintiles Clinical Trails

    In light of a recent FDA guidance, Andrew Garrett, Global Head of Biostatistics, Medical Writing and Regulatory Affairs for Quintiles, discusses how real-time collection of clinical research data can accelerate development timelines and better ensure patient safety. Listen to podcast

  • Quintiles Clinical Trails

    Multiple imputation (MI) is a methodology for dealing with missing data that has been steadily gaining wide usage in clinical trials. Read our paper which won Best in Biostatistics and Pharmacokinetics at the 2013 PharmaSUG Conference. Read paper

  • Quintiles Clinical Trails

    Sonia Davis discusses "Beyond Tables and P-values: Enhancing the Role of the Clinical Trial Team Statistician" at the FDA/Industry Statistics Workshop, on September 20, 2011. View presentation